NCT05193253View on ClinicalTrials.gov

Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

February 1, 2000

Primary Completion Date

November 30, 2018

Study Completion Date

December 21, 2021

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Radiofrequency ablation

Treatment-naive patients with solitary HCC \<= 3 cm who received ablation as the first-line treatment

PROCEDURE

Liver resection

Treatment-naive patients with solitary HCC \<= 3 cm who underwent liver resection as the first-line treatment

PROCEDURE

Liver transplantation

Treatment-naive patients with solitary HCC \<= 3 cm who were listed for liver transplantation as the first-line treatment

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT05193253 - Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less | Biotech Hunter | Biotech Hunter